Not medical advice
AMBITION 3: A Research Study Investigating How Well Zenagamtide at Higher Dose Levels Lowers Blood Sugar and Body Weight Compared to Semaglutide in People With Type 2 Diabetes Treated With Metformin,
Community vote
No Bro-Meter votes yet. Be the first. The verdict is only these votes — not FDA pages, imports, or ads.
Tried-it reports
Lived experience sits next to the community vote. Official sources never override either.
NOT_YET_RECRUITING · Novo Nordisk A/S Imported from ClinicalTrials.gov. This was filed by the system importer, not a fake user. Possible receipts (auto-attached from public APIs — verify before trusting): - ClinicalTrials.gov: AMBITION 3: A Research Study Investigating How Well Zenagamtide at Higher Dose Levels Lowers Blood Sugar and Body Weight Compared to Semaglutide in People With Type 2 Diabetes Treated With Metformin, SGLT2i, or Both — https://clinicaltrials.gov/study/NCT07931573
Not medical advice. We don't sell peptides. Votes and comments are community opinion, not clinical guidance.
Comments
No comments yet. Got receipts? Drop them.